Regulatory T Cells, Cell, vol.101, issue.5, pp.455-458, 2000. ,
DOI : 10.1016/S0092-8674(00)80856-9
URL : https://hal.archives-ouvertes.fr/hal-01358192
CD4 CD25 suppressor T cells: more questions than answers, Nat. Rev. Immunol, vol.2, pp.389-400, 2002. ,
???induced Colitis, The Journal of Experimental Medicine, vol.158, issue.4, pp.505-515, 2002. ,
DOI : 10.1016/S1074-7613(00)80005-9
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature, vol.223, issue.6915, pp.502-507, 2002. ,
DOI : 10.1038/nature01152
Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy, The Journal of Immunology, vol.169, issue.10, pp.5401-5404, 2002. ,
DOI : 10.4049/jimmunol.169.10.5401
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia, Journal of Clinical Investigation, vol.112, issue.11, pp.1688-1696, 2003. ,
DOI : 10.1172/JCI17702
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC281639/pdf
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies, Cancer, vol.298, issue.5, pp.1089-1099, 2003. ,
DOI : 10.1002/cncr.11618
Tumor rejection by in vivo administration of anti- CD25 (interleukin-2 receptor alpha) monoclonal antibody, Cancer Res, vol.59, pp.3128-3133, 1999. ,
Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses, The Journal of Experimental Medicine, vol.60, issue.6, pp.823-832, 2001. ,
DOI : 10.1084/jem.190.5.705
Depletion of CD25() CD4() T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8() T-cell-dependent immune defense of B16 melanoma, Cancer Res, vol.61, pp.8643-8646, 2001. ,
CD4+CD25+ regulatory T???cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative, European Journal of Immunology, vol.34, issue.2, pp.336-344, 2004. ,
DOI : 10.1002/eji.200324181
Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells, The Journal of Experimental Medicine, vol.59, issue.6, pp.771-782, 2004. ,
DOI : 10.1038/nature01152
Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation, The Journal of Immunology, vol.168, issue.9, pp.4272-4276, 2002. ,
DOI : 10.4049/jimmunol.168.9.4272
Regulatory CD4()CD25() T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer, Cancer Res, vol.61, pp.4766-4772, 2001. ,
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma, The Journal of Immunology, vol.169, issue.5, pp.2756-2761, 2002. ,
DOI : 10.4049/jimmunol.169.5.2756
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nature Medicine, vol.165, issue.9, pp.942-949, 2004. ,
DOI : 10.1016/S0022-1759(01)00359-3
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants, Science, vol.295, issue.5562, pp.2097-2100, 2002. ,
DOI : 10.1126/science.1068440
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis, Proc. Natl. Acad. Sci. USA, pp.12640-12645, 2004. ,
DOI : 10.1038/nri956
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell???dependent antitumor effects, Journal of Clinical Investigation, vol.114, issue.3, pp.379-388, 2004. ,
DOI : 10.1172/JCI21102DS1
What is a natural killer cell?, Nature Immunology, vol.3, issue.1, pp.6-8, 2002. ,
DOI : 10.1038/ni0102-6
On guard?activating NK cell receptors, Nature Immunology, vol.25, issue.1, pp.23-27, 2001. ,
DOI : 10.1038/83130
Natural Killer Cell Signaling Pathways, Science, vol.306, issue.5701, pp.1517-1519, 2004. ,
DOI : 10.1126/science.1103478
URL : https://hal.archives-ouvertes.fr/hal-00080580
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA, Science, vol.285, issue.5428, pp.727-729, 1999. ,
DOI : 10.1126/science.285.5428.727
Prevalent expression of the immunostimulatory MHC class I chain???related molecule is counteracted by shedding in prostate cancer, Journal of Clinical Investigation, vol.114, issue.4, pp.560-568, 2004. ,
DOI : 10.1172/JCI200422206
Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients, Annals of Surgery, vol.210, issue.4, pp.474-485, 1989. ,
DOI : 10.1097/00000658-198910000-00008
Human CD4+CD25+ regulatory T cells, Seminars in Immunology, vol.16, issue.2, pp.89-98, 2004. ,
DOI : 10.1016/j.smim.2003.12.005
Regulatory T Cells Is Mediated by Cell Surface???Bound Transforming Growth Factor ??, The Journal of Experimental Medicine, vol.157, issue.5, pp.629-644, 2001. ,
DOI : 10.1016/S0016-5085(00)70218-6
Human Thymocytes, The Journal of Experimental Medicine, vol.57, issue.3, pp.379-387, 2002. ,
DOI : 10.4049/jimmunol.167.1.553
T Suppressor Cell Clones Produce Transforming Growth Factor ??, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells, The Journal of Experimental Medicine, vol.44, issue.10, pp.1335-1346, 2002. ,
DOI : 10.1084/jem.20020642
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells, Proc. Natl. Acad. Sci. USA, pp.4120-4125, 2003. ,
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nature Immunology, vol.4, issue.4, pp.330-336, 2003. ,
DOI : 10.1038/ni904
Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype, The Journal of Experimental Medicine, vol.71, issue.1, pp.129-138, 2000. ,
DOI : 10.1111/j.1600-065X.1999.tb01292.x
Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells, The Journal of Immunology, vol.173, issue.2, pp.1444-1453, 2004. ,
DOI : 10.4049/jimmunol.173.2.1444
Induction of tumor immunity by removing CD25CD4 T cells: a common basis between tumor immunity and autoimmunity, J. Immunol, vol.163, pp.5211-5218, 1999. ,
Increase of regulatory T cells in the peripheral blood of cancer patients, Clin. Cancer Res, vol.9, pp.606-612, 2003. ,
CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction, Clinical Immunology, vol.112, issue.3, pp.258-267, 2004. ,
DOI : 10.1016/j.clim.2004.04.003
Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-?? and FOXP3, Journal of Clinical Investigation, vol.114, issue.1, pp.28-38, 2004. ,
DOI : 10.1172/JCI200420509
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma, The Journal of Immunology, vol.171, issue.12, pp.6891-6899, 2003. ,
DOI : 10.4049/jimmunol.171.12.6891
Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production, The Journal of Experimental Medicine, vol.147, issue.2, pp.287-296, 1998. ,
DOI : 10.1111/j.1600-065X.1996.tb00897.x
Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific, The Journal of Immunology, vol.164, issue.1, pp.183-190, 2000. ,
DOI : 10.4049/jimmunol.164.1.183
Cutting edge: control of CD8 T cell activation by CD4, 2001. ,
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse, Nature Genetics, vol.27, issue.1, pp.68-73, 2001. ,
DOI : 10.1038/83784
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer, The Journal of Experimental Medicine, vol.162, issue.10, pp.1325-1335, 2004. ,
DOI : 10.1038/ni857
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages, Nature Immunology, vol.1, issue.2, pp.119-126, 2000. ,
DOI : 10.1038/77793
A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac Disease, Immunity, vol.21, issue.3, pp.367-377, 2004. ,
DOI : 10.1016/j.immuni.2004.06.018
IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules, The Journal of Immunology, vol.172, issue.10, pp.5957-5966, 2004. ,
DOI : 10.4049/jimmunol.172.10.5957